Rational design of immunotoxins: current progress and future prospects.

Abstract

Immunotoxins are hybrid protein molecules created by the chemical or genetic fusion of an antibody and a protein toxin. Advances in the molecular engineering of monoclonal antibodies and toxins now permit the generation of a variety of immunotoxin types with properties optimized for the therapy of different malignancies. Novel research promises a new… (More)

Topics

  • Presentations referencing similar topics